SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 252.41 |
| Enterprise Value ($M) | 255.33 |
| Book Value ($M) | 45.77 |
| Book Value / Share | 1.05 |
| Price / Book | 5.51 |
| NCAV ($M) | 37.84 |
| NCAV / Share | 0.87 |
| Price / NCAV | 6.67 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.03 |
| Return on Assets (ROA) | -1.07 |
| Return on Equity (ROE) | -3.22 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.12 |
| Current Ratio | 6.12 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 112.66 |
| Assets | 120.59 |
| Liabilities | 74.82 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Janus Henderson Group Plc | 0.00 | -100.00 | |
| 13G/A | Point72 Asset Management, L.P. | 2.00 | -46.12 | |
| 13G/A | Integrated Core Strategies (us) Llc | 5.30 | 62.24 | |
| 13G/A | Adage Capital Management, L.P. | 9.99 | ||
| 13G | Suvretta Capital Management, Llc | 9.30 | ||
| 13G/A | EcoR1 Capital, LLC | 4.20 | -39.13 | |
| 13G/A | Armistice Capital, Llc | 4.99 | 17.64 | |
| 13G/A | Nantahala Capital Management, LLC | 9.90 | 83.85 | |
| 13G/A | Flynn James E | 3.39 | -50.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 64,311 | 380,471 | 16.90 | |
| 51,791 | 298,575 | 17.35 | |
| 62,589 | 205,953 | 30.39 | |
| 41,255 | 247,914 | 16.64 | |
| 63,750 | 728,378 | 8.75 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AADI – Aadi Bioscience, Inc. | ABVC – ABVC BioPharma, Inc. |
| ACB – Aurora Cannabis Inc. |